What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Statistics
Vic Hasselblad mainly investigates Internal medicine, Randomized controlled trial, Surgery, Cardiology and MEDLINE.
His work in Internal medicine is not limited to one particular discipline; it also encompasses Oncology.
His Randomized controlled trial research incorporates elements of Anesthesia, Catheter, Adverse effect and Sinus rhythm, Atrial fibrillation.
The Surgery study combines topics in areas such as Gastroenterology and Infarction.
As a member of one scientific family, Vic Hasselblad mostly works in the field of Cardiology, focusing on Placebo and, on occasion, Eptifibatide, Nesiritide and Brain natriuretic peptide.
His study in the field of Disease management also crosses realms of Outcome measures.
His most cited work include:
- Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. (964 citations)
- Effect of nesiritide in patients with acute decompensated heart failure. (942 citations)
- Interventions used in disease management programmes for patients with chronic illness-which ones work? Meta-analysis of published reports. (643 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Internal medicine, Cardiology, Surgery, Heart failure and Randomized controlled trial.
His studies in Myocardial infarction, Meta-analysis, Odds ratio, Acute decompensated heart failure and Confidence interval are all subfields of Internal medicine research.
The study of Cardiology is intertwined with the study of Placebo in a number of ways.
His Anesthesia research extends to Surgery, which is thematically connected.
The concepts of his Heart failure study are interwoven with issues in Hazard ratio, Heart disease and Intensive care medicine.
His research in Randomized controlled trial intersects with topics in Observational study and Clinical trial.
He most often published in these fields:
- Internal medicine (40.23%)
- Cardiology (23.62%)
- Surgery (16.33%)
What were the highlights of his more recent work (between 2013-2020)?
- Internal medicine (40.23%)
- Heart failure (14.87%)
- Cardiology (23.62%)
In recent papers he was focusing on the following fields of study:
Vic Hasselblad mostly deals with Internal medicine, Heart failure, Cardiology, Odds ratio and Randomized controlled trial.
His Internal medicine study combines topics from a wide range of disciplines, such as Diabetes mellitus and Placebo.
Vic Hasselblad usually deals with Heart failure and limits it to topics linked to Intensive care medicine and Clinical trial, Health care quality, Health services research, Preventive healthcare and Health care.
His work in Cardiology covers topics such as Survival rate which are related to areas like Inotrope.
His biological study spans a wide range of topics, including Anesthesia, Ventricular tachycardia, Odds and Catheter ablation.
His Randomized controlled trial study is focused on Surgery in general.
Between 2013 and 2020, his most popular works were:
- Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis. (73 citations)
- Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia (70 citations)
- Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): A randomised clinical trial (68 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Statistics
The scientist’s investigation covers issues in Internal medicine, Odds ratio, Cardiology, Nesiritide and Heart failure.
Vic Hasselblad mostly deals with Randomized controlled trial in his studies of Internal medicine.
Vic Hasselblad has researched Odds ratio in several fields, including Body mass index, Clopidogrel, Ticlopidine and Proton-pump inhibitor.
The study incorporates disciplines such as Platelet aggregation inhibitor and Surgery in addition to Cardiology.
His Nesiritide research integrates issues from Blood urea nitrogen, Renal function, Blood pressure, Acute decompensated heart failure and Placebo.
His Acute decompensated heart failure research focuses on Stepwise regression and how it connects with Clinical trial.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
